| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 145, 1280-1284, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
E Sarkozi, V Askanas and WK Engel
Department of Neurology, University of Southern California School of Medicine, Los Angeles.
Sporadic inclusion-body myositis is the most common progressive muscle disease of older patients. The muscle biopsy demonstrates mononuclear cell inflammation and vacuolated muscle fibers containing paired helical filaments and 6 to 10-nm fibrils, both resembling those of Alzheimer brain, and Congo-red positivity. Hereditary inclusion-body myopathy designates patients cytopathologically similar but without inflammation. In both muscle diseases, prion, and several proteins characteristic of Alzheimer brain--eg, beta-amyloid protein and hyperphosphorylated tau (which normally are expressed mainly in neurons), and apolipoprotein E--are abnormally accumulated in vacuolated muscle fibers, by unknown mechanisms. We now demonstrate in both muscle diseases that prion mRNA is strongly expressed in the vacuolated muscle fibers, which suggests that their accumulated prion protein results, at least partly, from increased gene expression. This, to our knowledge, is the first demonstration of abnormally increased prion mRNA in human disease. Another novel finding is the increased prion mRNA in human muscle macrophages, and both increased prion protein and prion mRNA in regenerating muscle fibers. The latter indicates that prion may play a role in human muscle development.
This article has been cited by other articles:
 |
|
 |
|
  S. Huang, J. Liang, M. Zheng, X. Li, M. Wang, P. Wang, D. Vanegas, D. Wu, B. Chakraborty, A. P. Hays, et al. Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice PNAS, April 17, 2007; 104(16): 6800 - 6805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Greenberg, D. Sanoudou, J. N. Haslett, I. S. Kohane, L. M. Kunkel, A. H. Beggs, and A. A. Amato Molecular profiles of inflammatory myopathies Neurology, October 22, 2002; 59(8): 1170 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Randomized pilot trial of {beta}INF1a (Avonex) in patients with inclusion body myositis Neurology, November 13, 2001; 57(9): 1566 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Orth, S. J. Tabrizi, and A. H. V. Schapira Sporadic inclusion body myositis not linked to prion protein codon 129 methionine homozygosity Neurology, October 24, 2000; 55(8): 1235 - 1235. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Askanas and W. K. Engel Does Overexpression of ßAPP in Aging Muscle Have a Pathogenic Role and a Relevance to Alzheimer's Disease? : Clues from Inclusion Body Myositis, Cultured Human Muscle, and Transgenic Mice Am. J. Pathol., December 1, 1998; 153(6): 1673 - 1677. [Full Text] [PDF]
|
|
|
|
 |
|
 V. ASKANAS, W. K. ENGEL, and R. B. ALVAREZ Fourteen Newly Recognized Proteins at the Human Neuromuscular Junctions-and Their Nonjunctional Accumulation in Inclusion-Body Myositisa Ann. N.Y. Acad. Sci., May 13, 1998; 841(1): 28 - 56. [Full Text]
|
|
|
|
 |
|
 A. M. Haywood Transmissible Spongiform Encephalopathies N. Engl. J. Med., December 18, 1997; 337(25): 1821 - 1828. [Full Text] [PDF]
|
|
|
|
|
|
C. Lemaire-Vieille, T. Schulze, V. Podevin-Dimster, J. Follet, Y. Bailly, F. Blanquet-Grossard, J.-P. Decavel, E. Heinen, and J.-Y. Cesbron Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice PNAS, May 9, 2000; 97(10): 5422 - 5427. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
